Invention Grant
- Patent Title: Combination therapy with an anti-hyaluronan agent and therapeutic agent
-
Application No.: US13815804Application Date: 2013-03-15
-
Publication No.: US09913822B2Publication Date: 2018-03-13
- Inventor: Daniel C. Maneval , H. Michael Shepard , Curtis B. Thompson
- Applicant: Daniel C. Maneval , H. Michael Shepard , Curtis B. Thompson
- Applicant Address: US CA San Diego
- Assignee: Halozyme, Inc.
- Current Assignee: Halozyme, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Dentons US LLP
- Agent Stephanie Seidman
- Main IPC: A61K47/48
- IPC: A61K47/48 ; A61K31/56 ; A61K31/7068 ; A61K31/337 ; A61K38/47 ; A61K31/37 ; A61K31/42 ; A61K31/573 ; A61K31/706 ; A61K31/7076 ; A61K31/7088 ; C12N9/06 ; C12N9/26 ; A61K45/06 ; A61K9/00 ; A61K47/60 ; A61K47/56 ; A61K47/64
Abstract:
Provided herein is combination therapy containing an anti-hyaluronan agent, such as a polymer-conjugated hyaluronan-degrading enzyme, and a tumor-targeted taxane, and optionally a further chemotherapeutic agent such as a nucleoside analog. The combination therapy can be used in methods of treating cancers, and in particular solid tumor cancers.
Public/Granted literature
- US20130302400A1 Combination therapy with an anti-hyaluronan agent and therapeutic agent Public/Granted day:2013-11-14
Information query
